The Company was incorporated as `Windlas Biotech Limited' on February 19, 2001 at New Delhi as a public limited company under the Companies Act, 1956 and was granted a certificate of incorporation by RoC Delhi. Further, the Company received the certificate for commencement of business on March 5, 2001 from the RoC Delhi. The Registered Office of the Company was shifted from the state of Delhi to the state of Uttarakhand pursuant to a special resolution passed by the Shareholders on August 22, 2009. The alteration with respect to the place of the Registered Office was confirmed by the order of the Company Law Board, New Delhi on August 5, 2010 and a fresh certificate of registration was issued by the Registrar of Companies, Uttar Pradesh and Uttarakhand located at Kanpur on February 18, 2011. Subsequently, the Company was converted into a private limited company pursuant to a special resolution passed by the Shareholders on March 30, 2016 and a fresh certificate of incorporation consequent upon conversion and change of name to `Windlas Biotech Private Limited' was granted by the Registrar of Companies, Uttarakhand located at Kanpur on July 22, 2016. the Company was converted from a private limited company to a public limited company pursuant to a special resolution passed by the Shareholders on April 3, 2021, and the name of the Company was changed to `Windlas Biotech Limited'. A fresh certificate of incorporation dated April 15, 2021 consequent upon change of name on conversion to a public limited company was granted by the RoC.Major events and milestones of the Company :2001- Commenced operations at Dehradun Plant - I situated at 40/1, Mohabewala Industrial Area, Dehradun 248 110 and initiated commercial production2009- Commenced operations at Dehradun Plant - IV situated at plot no. 183 and 192, Mohabewala Industrial Area, Dehradun 248 1102010- Revenues crossed Rs. 1,000 million for the FY 2009-102014- Received first USFDA inspection clearance for the WHC Plant- Revenues crossed Rs. 2,000 million for the FY 2013-14- Commenced operations at Dehradun Plant - II situated at khasra no. 141 to 143 and 145, Mohabewala Industrial Area, Dehradun 248 1102015- Investment of Rs. 750 million from Tano India Private Equity Fund II2017- Revenues crossed Rs. 3,000 million for the FY 2016-172018- Launched first product in the United States from the Dehradun Plant - IV situated at plot no. 183 and 192, Mohabewala Industrial Area, Dehradun 248 110- Commenced operations at Dehradun Plant - III situated at plot no. 39, Pharmacity, Selaqui, Dehradun 248 1972021- Approval of Scheme of Amalgamation of the erstwhile subsidiary, Windlas Healthcare, with and into the Company 2022 -Company received certificate of Good Manufacturing Practices (GMP) from SAHPRA (South African Health Products Regulatory Authority).